Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 182Ovarian Neoplasms 92Carcinoma, Ovarian Epithelial 46Fallopian Tube Neoplasms 35Endometrial Neoplasms 29Peritoneal Neoplasms 23Stomach Neoplasms 18Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Neoplasms 11Vulvar Neoplasms 9Recurrence 9Lung Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Locally Advanced Cervical Cancer 7Brenner Tumor 7Uterine Neoplasms 6Testicular Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Neoplasm Metastasis 6Carcinoma 6Urinary Bladder Neoplasms 5Sarcoma 5Colonic Neoplasms 5Breast Neoplasms 5Vaginal Neoplasms 4Triple Negative Breast Neoplasms 4Teratoma 4Small Cell Lung Carcinoma 4

Interventions

Radiotherapy 2TP protocol 1Paclitaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Recurrence, Local × Cisplatin × Gynecologic × Clear all
NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
36 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡